Mulling It Over 100% FDI allowed in pharma sector through automatic route Seven top Indian firms have been acquired by MNCs in the past six years Fear of price rise in generic medicines if MNCs control market Health, commerce ministries want FDI to go through approvals PMO meeting key ministries next month to take a decision *** Prime Minister Manmohan Singh has always been firm in reminding domestic industry that their fear...
More »SEARCH RESULT
Total Matching Records found : 326
Panel for guaranteed health coverage for all by Aarti Dhar
It will be offered as National Health Package for all common conditions Strongly recommending a re-configuration of the entire health system where the government will have a major role to play, a high level expert group on Universal Health Coverage (UHC) has proposed making health care an entitlement to every citizen. The group suggested that health care be offered as a National Health Package (NHP) covering all common conditions and high-impact health...
More »India’s drug ‘lifeline’ under threat by Mari Marcel Thekaekara
I never dreamed I’d ever wave the flag for Indian pharmaceutical companies. But some years ago, I discovered that India provides essential drugs to most of the world’s economically deprived nations. Many of the poorest people in India and Africa could not afford basic drugs if it were not for Indian drug companies. Astonishingly, India is known as the ‘pharmacy to the developing world’ and is something of a hero in...
More »Useless pharmaceutical studies cause real harm by Carl Elliott
Last month, the Archives of Internal Medicine published a scathing reassessment of a 12-year-old research study of Neurontin, a seizure drug made byPfizer. The study, which had included more than 2,700 subjects and was carried out by Parke-Davis (now part of Pfizer), was notable for how poorly it was conducted. The investigators were inexperienced and untrained, and the design of the study was so flawed it generated few if any...
More »UN welcomes pact to improve access of patented AIDS drugs in poor countries
-The United Nations The United Nations agency mandated to spearhead the global response to HIV/AIDS today welcomed the new license agreement between the Medicines Patent Pool and the pharmaceutical company Gilead Sciences to increase access to antiretroviral therapy in developing countries. The Joint UN Programme on HIV/AIDS (UNAIDS) said the agreement marks the first time a pharmaceutical company has signed an agreement with the Medicines Patent Pool, describing it as a turning...
More »
